154 related articles for article (PubMed ID: 37866412)
1. Periocular and ocular surface nonmelanoma skin cancer.
Hooper J; Shao K; Feng PW; Falcone M; Feng H
Clin Dermatol; 2024; 42(1):71-77. PubMed ID: 37866412
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment for ocular surface squamous neoplasia.
Monroy D; Serrano A; Galor A; Karp CL
Eye (Lond); 2023 Apr; 37(5):885-893. PubMed ID: 36754986
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
Kim BH; Kim MK; Wee WR; Oh JY
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
[TBL] [Abstract][Full Text] [Related]
4. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
7. Topical pharmacotherapy for ocular surface squamous neoplasia: systematic review and meta-analysis.
Kozma K; Dömötör ZR; Csutak A; Szabó L; Hegyi P; Erőss B; Helyes Z; Molnár Z; Dembrovszky F; Szalai E
Sci Rep; 2022 Aug; 12(1):14221. PubMed ID: 35987957
[TBL] [Abstract][Full Text] [Related]
8. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of amniotic membrane transplantation combined with mitomycin C for conjunctival reconstruction after ocular surface squamous neoplasia excision.
Hanada K; Nishikawa N; Miyokawa N; Yoshida A
Int Ophthalmol; 2017 Feb; 37(1):71-78. PubMed ID: 27061904
[TBL] [Abstract][Full Text] [Related]
10. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
[TBL] [Abstract][Full Text] [Related]
11. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
McKelvie PA; Daniell M
Br J Ophthalmol; 2001 Sep; 85(9):1115-9. PubMed ID: 11520767
[TBL] [Abstract][Full Text] [Related]
12. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
[TBL] [Abstract][Full Text] [Related]
13. American Joint Committee on Cancer Staging and clinicopathological high-risk predictors of ocular surface squamous neoplasia: a study from a tertiary eye center in India.
Chauhan S; Sen S; Sharma A; Tandon R; Kashyap S; Pushker N; Vanathi M; Sharma N
Arch Pathol Lab Med; 2014 Nov; 138(11):1488-94. PubMed ID: 25357110
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
Viani GA; Fendi LI
Arq Bras Oftalmol; 2017; 80(2):131-136. PubMed ID: 28591290
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Anterior Segment Optical Coherence Tomography in Intraepithelial Versus Invasive Ocular Surface Squamous Neoplasia.
Singh S; Mittal R; Ghosh A; Tripathy D; Rath S
Cornea; 2018 Oct; 37(10):1292-1298. PubMed ID: 29985794
[TBL] [Abstract][Full Text] [Related]
16. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
Singh M; Gautam N; Kaur M
Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
[TBL] [Abstract][Full Text] [Related]
17. The Management of Ocular Surface Squamous Neoplasia (OSSN).
Yeoh CHY; Lee JJR; Lim BXH; Sundar G; Mehta JS; Chan ASY; Lim DKA; Watson SL; Honavar SG; Manotosh R; Lim CHL
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614155
[TBL] [Abstract][Full Text] [Related]
18. Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia.
Polski A; Sibug Saber M; Kim JW; Berry JL
Clin Exp Ophthalmol; 2019 Mar; 47(2):193-200. PubMed ID: 30156057
[TBL] [Abstract][Full Text] [Related]
19. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
[TBL] [Abstract][Full Text] [Related]
20. Topical chemotherapy for ocular surface squamous neoplasia.
Nanji AA; Sayyad FE; Karp CL
Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
